Breast Imaging Technologies Market - By Technology (Ionizing Breast Imaging Technologies (Mammography (Digital Mammography, 3D Mammogram, and Analog), MBI, PET-CT, PEM), Non-Ionizing Breast Imaging Technologies (Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, and Breast Thermography)), By End User (Hospitals, Diagnostic Imaging Centers, and Ambulatory Surgical Centers), By Region - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Breast Imaging Technologies market size was valued at USD 5250.9 million in 2020 and is expected to reach USD 11763 million by 2030, growing at a CAGR of 8.4% during the forecast period. Breast imaging is a subspecialty of diagnostic radiology. It includes a range of imaging procedures with variety of technologies to screen and tools for detection, and diagnoses breast cancer. If cancer is detected, these tests help the doctors to find the cancer type, as well as determine the stage and location of the cancer. This market is projected to witness significant growth during the forecast period due to increase in rate of breast cancer worldwide and practical initiatives by healthcare organizations to increase awareness about early breast cancer detection. These technologies are used to obtain high-resolution descriptions of breast tissues. These imaging modalities, such as ionizing and non-ionizing imaging technologies, aid in the early detection and diagnosis of breast diseases, especially breast cancer in women. Ionizing breast imaging modalities are widely adopted for the screening of breast cancer.  Breast cancer is the second most leading reason of death in women after cervical cancer. According to the estimates of GLOBOCAN, breast cancer is the most common form of cancer among women, with approximately 1.67 million new cancer cases diagnosed in 2012, and it is expected to affect more than 1.97 million individuals by 2020.

Market Segmentation:

On the basis of technology, the market is bifurcated into ionizing breast imaging technology and non-ionizing breast imaging technology. Ionizing technology further divided into mammography, MBI, PET-CT and PEM. Mammography further divided into Digital Mammography, 3D Mammogram, Analog. Non-ionizing technology classified into Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography. On the basis of end users, the market is segmented into hospitals, diagnostic imaging centers, and ambulatory surgical centers. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Market Dynamics and Factors:

The launch of breast imaging technologies is essential to restrict the chances of breast cancer and its associated risk factors. Therefore, increase in frequency of breast cancer is estimated to increase the breast imaging technologies market share. Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors and the market is growing at CAGR 15.11% due to the many initiatives taken from the United States Preventive Services Task Force has developed guidelines for mammography screening. Furthermore, the National Cancer Institute conducts and facilitates many organizations to develop their guidelines. Healthcare organizations and governments around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. Additionally, the ability of these devices to create 3D images of the breast tissue, increases the detection rate of breast tumors, which also further contributed to their increased demand. In count, there have been a number of advancements in the field that prevent over-diagnosis and provide better sensitivity to detect smaller carcinomas. These continuous advancements in this field are anticipated to augment the mammography segment of global breast cancer screening tests market.  This remains a major driver for the mammography market and is expected to boost the market during the forecast period.

Geographic Analysis:

The number of cancer patients in North America has witnessed a considerable rise. Prostate and breast cancer are the most common forms of cancer in the region.  The United States will sustain a 6.1% growth force. Europe continue to remain an important element in the world economy demand in the region will come from the rest of the European markets. Asia Pacific is set to register remarkable growth during the forecast period on account of positive government initiatives to educate women regarding breast cancer and implementing effective diagnosis at primary healthcare centers. Middle East & Africa and Latin America serve as a profitable market for key players to promote business expansion through inorganic and organic market growth strategies.

Competitive Scenario:

Some of the major players operating in global breast imaging technologies market  are, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Gamma Medical Inc., Hologic, Inc., General Electric Company, Siemens AG, TOSHIBA CORPORATION, Sonocine Inc., Aurora Imaging Technology, Inc., Dilon Technologies, Inc., Testo AG, Planmeca OY, Imaging Diagnostic Systems, Inc.

Breast Imaging Technologies Market Report Scope